-

White Biotechnology Market Analysis and Forecast Report 2025-2034: Strategic Alliances and M&As Set to Shape White Biotechnology Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering.

White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization.

Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools - machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation - are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.

The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments - from enzyme producers like Novozymes and DuPont to bio-based materials pioneers - indicating ample room for new entrants.

As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.

White Biotechnology Market Key Players and Competition Synopsis

The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators.

Leading companies - such as Novozymes, DuPont de Nemours, BASF, Evonik Industries AG - leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale.

At the same time, agile pure-play biotechnology companies - Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks - are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs.

Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships - linking chemical giants with biotech startups - continue to reshape market share, drive consolidation and foster next-generation technology transfer.

Some prominent names established in the white biotechnology market include:

  • Medtronic
  • Novozymes
  • BASF
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniels Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

Key Attributes:

Report Attribute Details
No. of Pages 120
Forecast Period 2025 - 2034
Estimated Market Value (USD) in 2025 $337.56 Billion
Forecasted Market Value (USD) by 2034 $672.92 Billion
Compound Annual Growth Rate 7.9%
Regions Covered Global 

Key Topics Covered:

1. Markets: Industry Outlook

1.1 Trends: Current and Future Impact Assessment

1.2 Stakeholder Analysis

1.3 Market Dynamics Overview

1.4 Investment Landscape and R&D Trends

1.5 Future Outlook and Market Roadmap

2. White Biotechnology Market (by Application)

2.1 Application Segmentation

2.2 Application Summary

2.3 White Biotechnology Market (by Application)

2.3.1 Bioenergy

2.3.2 Food and Feed Additives

2.3.3 Pharmaceutical Ingredients

2.3.4 Personal Care and Household Products

2.3.5 Others

3. White Biotechnology Market (by Product)

3.1 Product Segmentation

3.2 Product Summary

3.3 White Biotechnology Market (by Product Type)

3.3.1 Biochemical

3.3.2 Biofuel

3.3.3 Biomaterial

3.3.4 Bioproduct

4. White Biotechnology Market (by Region)

4.1 White Biotechnology Market (by Region)

4.2 North America

4.3 Europe

4.4 Asia-Pacific

4.5 Rest-of-the-World

5. Markets - Competitive Benchmarking & Company Profiles

5.1 Next Frontiers

5.2 Geographic Assessment

5.3 Company Profiles

  • Medtronic
  • Novozymes
  • BASF SE
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniels Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

For more information about this report visit https://www.researchandmarkets.com/r/ula8vi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Europe Meat Snacks Market Growth Trends and Forecast Report 2025-2033 | French and German Markets Lead the $6.9 Bn Market with Innovation and New Gourmet Offerings - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Meat Snacks Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Europe meat snacks market was worth US$ 2.99 billion in 2024 and is expected to register a CAGR of 9.79% between 2025 and 2033 to reach US$ 6.9 billion by 2033 The market is fueled by rising consumer need for on-the-go high-protein snack foods and a growing inclination towards natural and less processed foo...

Dairy Alternatives Market Growth Trends and Forecast Report 2025-2033 | Key Players like Danone and SunOpta Innovate to Meet Rising Lactose-Free and Vegan Demands - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Dairy Alternatives Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Dairy Alternative Market is expected to reach US$ 83.94 billion in 2033 from US$ 32.24 billion in 2024, with a CAGR of 11.22% from 2025 to 2033. The growing consumer focus on sustainability, health, and the launch of novel product offerings are driving the size of the dairy alternatives market. Plant-based...

Bispecific Antibodies Market Industry, Global Forecasts and Key Players to 2035: Over 400 Bispecific Antibody Candidates Under Research Worldwide - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Geographical Regions and Key Players" report has been added to ResearchAndMarkets.com's offering. The global bispecific antibodies market is estimated to grow from USD 5.6 billion in 2025, to USD 16.8 billion by 2035, at a CAGR of 9.5% during the forecast period, to 2035. The discovery of the therapeutic potential...
Back to Newsroom